- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02635087
microRNAs Tool for Stratifying Stage II Colon Cancer
December 29, 2015 updated by: Wu Song, First Affiliated Hospital, Sun Yat-Sen University
microRNAs Tool for Stratifying Stage II Colon Cancer:a Perspective Study of Adjuvant Chemotherapy
The investigators discover the investigators' miRNA tool can be a useful tool to predict the patients with stage II colon who can benefit from chemotherapy.Then the investigators plan to make an observation study that may validation this tool.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is an observation study.
The investigators recruit patients who agree to use their postoperative specimen for miRNA tool examination and receive the investigators' follow up.Their receiving chemotherapy or not will decided by their doctors.
The investigators just see whether the stratifying tool could predict prognosis.
Study Type
Observational
Enrollment (Anticipated)
630
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zehong Chen, master
- Phone Number: +8613751773229
- Email: Stevenchen8@qq.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Recruiting
- FisrtSunYetsen
-
Contact:
- Zehong Chen, master
- Phone Number: 8613751773229
- Email: stevenchen8@qq.com
-
Contact:
- Wu Song, doctor
- Phone Number: 8613751773229
- Email: songwu@mail.sysu.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients who had stage II colon cancer and received surgery.They agree to use miRNA tool to test their postoperative specimen.
Description
Inclusion Criteria:
- The informed consent has been obtained from the patient.
- With confirmed diagnosis of stage II colon cancer.
- With moderate/good ECOG health rating (PS): 0-1 score.
- The patient receive no anti-cancer treatment before primary surgery.
- The patient receive radical operation for colon cancer with negative margin.
Exclusion Criteria:
- With severe comorbidities, such as cardiovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, and chronic renal dysfunction.
- With bad compliance or contraindication to enrollment.
- Pregnant woman or lactating woman.
- With contraindication to receive adjuvant chemotherapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
high risk group
the miRNA tool predict this group of patients as "high risk"
|
patients to be assessed by the miRNA tool.
MicroRNA tool contains miRNA of miR-21、miR-20a-5p、miR-103a-3p、miR-106b-5p、miR-143-5p and miR-215.
Investigators evaluate these miRNA status of surgical specimens using qRT-PCR and calculate their risk score(risk score =(0.108×status of miR-21-5p)+(0.086×status of miR-20a-5p)+(0.240×status of miR-103a-3p)+(0.095×status of miR-106b-5p)- (0.238×status of miR-143-5p)-(0.237×status of miR-215),low expression status equals 0 and high expression status equals 1.Then we determine the patients who with a score higher than 1 as exposed patient.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
DFS
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
OS
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Wu Song, MD, First Affiliated Hospital, Sun Yat-Sen University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Anticipated)
July 1, 2020
Study Completion (Anticipated)
July 1, 2025
Study Registration Dates
First Submitted
December 16, 2015
First Submitted That Met QC Criteria
December 17, 2015
First Posted (Estimate)
December 18, 2015
Study Record Updates
Last Update Posted (Estimate)
December 30, 2015
Last Update Submitted That Met QC Criteria
December 29, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015[112]
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Neoplasms
-
Imperial College LondonCompletedColonic Diseases | Colonic Polyp | Colonic Neoplasms | Colonic Cancer | Colonic Adenocarcinoma | Colonic Adenoma | Colonic Carcinoma | Colonic Dysplasia | Colon Hyperplastic PolypUnited Kingdom
-
Hospital Universitario de MóstolesCompletedColonic Polyp | Colonic Neoplasms | Colonic Cancer
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Tan Tock...CompletedColonic Polyp | Colonic Neoplasms | Colonic DysplasiaSingapore
-
Oxford University Hospitals NHS TrustCompletedRectal Cancer | Ulcerative Colitis | Colonic Cancer | Colonic DiverticulumUnited Kingdom
-
Institute of Gastroenterology and Advance EndoscopyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Adenoma | Colonic DiseaseArgentina
-
The University of Hong KongRecruitingColonic Polyp | Colonic Cancer | Colonic AdenomaHong Kong
-
University of Turin, ItalyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Dysplasia
-
The University of Hong KongUnknownColonic Polyps | Colonic CancersHong Kong
-
UNC Lineberger Comprehensive Cancer CenterPfizer; AmgenActive, not recruitingColon Cancer | Colonic Cancer | Cancer of the Colon | Colon Neoplasms | Neoplasms, ColonicUnited States
-
Chinese University of Hong KongCompleted
Clinical Trials on miRNA tool
-
University of CataniaCompleted
-
Bezmialem Vakif UniversityCompleted
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Recruiting
-
University of GaziantepCompletedMultiple Sclerosis | Biomarker | miRNA | Epigenetic
-
Royal Cornwall Hospitals TrustCompleted
-
Istituto Ortopedico RizzoliRecruitingAdolescent Idiopathic ScoliosisItaly
-
Université Catholique de LouvainRecruiting
-
Virginia Commonwealth UniversityOhio State UniversitySuspendedCerebrovascular DisordersUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Lei LiUnknownOvarian Cancer | High Grade Serous Carcinoma | Prognosis | Early Diagnosis | ExosomesChina